订阅小程序
旧版功能

Randomized Phase II/III Trial of Gemcitabine Plus Nab-Paclitaxel Versus Concurrent Chemoradiotherapy with S-1 As Neoadjuvant Treatment for Borderline Resectable Pancreatic Cancer: GABARNANCE Study.

Journal of Clinical Oncology(2024)

引用 0|浏览6
关键词
261-492-3532-2370-7650-2700,298-145-222-3672,261-566-148-440-5779,613-225-2575-3984,261-566-148-440-7316,3618,219,3618,176
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要